How do Extracellular Vesicles (EVs) influence nutrition?
The study of extracellular vesicles (EVs) has emerged as a novel area of research in understanding how food and the gut microbiome influence health. EVs are nano and microscale lipid membrane-bound structures that transport a variety of molecules, such as proteins, lipids, metabolites, nucleic acids, and glycans. These vesicles are secreted by cells into extracellular space and play a crucial role in intercellular communication, tissue homeostasis, and influencing various physiological and pathological processes.
What are Extracellular Vesicles?
EVs are classified into three types based on their size and biogenesis: exosomes (30-150 nm), microvesicles (150-1000 nm), and apoptotic bodies (larger than 1000 nm). They carry a broad spectrum of biomolecules that can regulate several aspects of cellular function, making them key players in many physiological processes. Their ability to traverse biological barriers, such as the gut lining, blood-brain barrier, and vascular endothelium, highlights their potential to affect distant organs and tissues, influencing systemic health, including metabolism and immune function.
EVs and the gut microbiome
A key area of interest is how food-derived EVs, referred to as nutriEVs, interact with the gut microbiome. The gut microbiome plays a significant role in the digestion and absorption of nutrients, and recent research has shown that EVs are involved in this process. Food-derived EVs may have the ability to cross the intestinal barrier and enter systemic circulation, where they can interact with immune cells and other tissues. This highlights the role of EVs in nutrient transfer and how they influence the metabolic processes that occur after food ingestion.
These food-derived EVs can interact with the gut microbiome, influencing how nutrients are absorbed and processed. For example, gut bacteria can ferment dietary fibers into short-chain fatty acids (SCFAs), which not only enhance insulin sensitivity but also influence appetite-regulating hormones. EVs play a role in carrying these metabolites across the intestinal lining, contributing to systemic metabolic health and the regulation of obesity and metabolic dysfunction.
The role of glycosylation in EV function
A critical aspect of EV functionality is the glycosylation of their surface proteins. Glycans, sugar chains attached to proteins or lipids, play an essential role in determining how EVs interact with cells. The glycans on the surface of food-derived EVs can impact how these vesicles are targeted to specific tissues, and whether they can cross biological barriers. The glycan composition also influences the vesicles’ ability to interact with the gut microbiome and immune cells, thus contributing to various aspects of metabolic regulation.
Changes in the glycosylation of EVs have been linked to diseases, including metabolic disorders. These alterations can affect the EVs’ interaction with cells and tissues, potentially leading to disrupted immune responses and metabolic dysfunction. Therefore, studying the glycan composition of EVs offers insights into how diet and the gut microbiome can influence systemic health, including conditions such as obesity, diabetes, and metabolic syndrome.
EVs in obesity and metabolic disorders
Obesity is a major risk factor for metabolic disorders like type 2 diabetes, cardiovascular disease, and insulin resistance. A growing body of evidence suggests that EVs play a central role in the development of these diseases by influencing appetite control, fat storage, and systemic inflammation. The interaction between food-derived EVs and the gut microbiome is crucial in regulating metabolic processes. EVs containing bioactive molecules, such as lipids, proteins, and SCFAs, can regulate insulin sensitivity, promote fat breakdown, and control appetite-regulating hormones.
For example, EVs derived from fermented foods can promote gut health by maintaining the intestinal barrier and reducing inflammation, processes that are essential for preventing or mitigating metabolic disorders. Moreover, EVs derived from adipose tissue may transmit signals related to fat storage and energy regulation to other organs, including the liver and pancreas, thus influencing overall metabolic function.
Potential for precision medicine and diagnostics
The ability of EVs to cross biological barriers and influence distant tissues presents exciting possibilities for precision medicine and diagnostics. By analysing the glycan profiles and molecular cargo of food-derived EVs, it may be possible to develop new, non-invasive diagnostic methods for monitoring the impact of nutrition on health. These methods could provide real-time insights into how specific foods or dietary patterns influence metabolic health, immune function, and gut microbiome composition.
In addition, EVs can potentially serve as biomarkers for assessing the effects of nutrition on obesity, insulin resistance, and other metabolic disorders. Their presence and composition in body fluids such as blood or saliva could be tracked to understand individual responses to specific dietary interventions. This approach could pave the way for more personalized strategies in preventing and treating diet-related diseases, such as obesity and diabetes.
Why this matters for the future of nutrition
Extracellular vesicles play a crucial role in how food and the gut microbiome influence human health, particularly in the context of digestion, metabolism, and immune regulation. Food-derived EVs, or nutriEVs, are important mediators of nutrient absorption and metabolism, carrying key molecules from the gut to other organs and tissues. Their glycan composition plays a central role in determining how they interact with cells, tissues, and the microbiome, influencing metabolic processes. As research into EVs continues to evolve, their role in managing metabolic disorders such as obesity and diabetes could lead to new approaches in precision nutrition and therapeutic interventions. By leveraging these insights, researchers hope to develop novel, non-invasive diagnostic tools and therapies to address the rising global challenges of nutrition-related diseases.
The NutriEV project focuses on the role of food and plant-derived EVs in influencing gut health and metabolic processes. Specifically, it investigates how nutriEVs, including their glycan components, impact the gut microbiome and contribute to the regulation of metabolic disorders like obesity. By studying the biomolecular composition of these EVs in raw and fermented foods, the project aims to better understand how they affect the immune system and systemic health. The research extends to in vitro models, including organoids, as well as in vivo models using mice and human trials, with the goal of developing non-invasive biosensor technologies to track the effects of diet on health in real time. By providing deeper insights into the role of nutriEVs in metabolic regulation, the NutriEV project aims to revolutionize our understanding of nutrition and its potential for precision medicine.